KCS Wealth Advisory acquired a new position in shares of UnitedHealth Group Inc (NYSE:UNH) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 3,727 shares of the healthcare conglomerate’s stock, valued at approximately $822,000.
Other institutional investors have also modified their holdings of the company. Blue Chip Partners Inc. purchased a new position in UnitedHealth Group during the 2nd quarter worth $110,000. Bruderman Asset Management LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the last quarter. BDO Wealth Advisors LLC purchased a new position in UnitedHealth Group during the 2nd quarter worth $121,000. Finally, Acrospire Investment Management LLC grew its position in UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after purchasing an additional 400 shares during the last quarter. 86.00% of the stock is currently owned by institutional investors.
Shares of UnitedHealth Group Inc (NYSE:UNH) opened at $229.37 on Friday. The company has a quick ratio of 0.70, a current ratio of 0.73 and a debt-to-equity ratio of 0.58. UnitedHealth Group Inc has a 52 week low of $156.49 and a 52 week high of $250.79. The company has a market cap of $222,270.00, a PE ratio of 24.14, a P/E/G ratio of 1.32 and a beta of 0.70.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be paid a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.31%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 31.58%.
In related news, Director Kenneth Irwin Shine sold 198 shares of the firm’s stock in a transaction dated Friday, January 19th. The shares were sold at an average price of $242.55, for a total value of $48,024.90. Following the completion of the sale, the director now owns 1,790,567 shares in the company, valued at $434,302,025.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the completion of the sale, the director now owns 61,137 shares of the company’s stock, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Insiders sold 53,396 shares of company stock valued at $12,262,067 in the last quarter. Company insiders own 0.89% of the company’s stock.
Several research analysts have issued reports on the stock. Mizuho reissued a “buy” rating on shares of UnitedHealth Group in a research report on Tuesday, October 24th. Citigroup raised their price objective on shares of UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $215.00 to $225.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 29th. Cantor Fitzgerald restated a “buy” rating and issued a $235.00 target price on shares of UnitedHealth Group in a research note on Tuesday, January 16th. Finally, Raymond James Financial restated a “buy” rating on shares of UnitedHealth Group in a research note on Wednesday, December 6th. Two research analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $243.22.
WARNING: “KCS Wealth Advisory Invests $822,000 in UnitedHealth Group Inc (UNH) Stock” was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this report on another website, it was illegally copied and republished in violation of US & international copyright & trademark legislation. The correct version of this report can be accessed at https://www.chaffeybreeze.com/2018/02/18/kcs-wealth-advisory-invests-822000-in-unitedhealth-group-inc-unh-stock.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.